Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 251586
                    [Title] => Reducing diabetes risk
                    [Summary] => Treatment of type 2 diabetes has recently acquired a new development as the European Commission (EC) recently approved the use of the weight loss medication, orlistat, in managing and reducing the risk for developing type 2 diabetes. 


Its efficacy in reducing the risk of developing type 2 diabetes is backed by the landmark XENDOS (Xenical in the prevention of Diabetes in Obese Subjects) study, which showed for the first time that a fat blocker medication can significantly lessen the risk of developing type 2 diabetes.


                    [DatePublished] => 2004-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 250481
                    [Title] => Watch out for this sly killer on the loose
                    [Summary] => This killer syndrome is on the loose, preying on millions of unsuspecting victims. Victim No. 1: Ricardo B., 54-year-old insurance manager, complained of no symptoms previously and could still play 18 holes of golf without using the golf cart; just slightly overweight; with borderline blood pressure (BP) and blood sugar (BS); low high-density lipoprotein or HDL (good cholesterol) and elevated triglycerides; rushed to the emergency room for an acute myocardial infarction (heart attack); and fortunately survived. 


                    [DatePublished] => 2004-05-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1769986
                    [AuthorName] => The Fame Health Bureau
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

DR. JOHN FOREYT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 251586
                    [Title] => Reducing diabetes risk
                    [Summary] => Treatment of type 2 diabetes has recently acquired a new development as the European Commission (EC) recently approved the use of the weight loss medication, orlistat, in managing and reducing the risk for developing type 2 diabetes. 


Its efficacy in reducing the risk of developing type 2 diabetes is backed by the landmark XENDOS (Xenical in the prevention of Diabetes in Obese Subjects) study, which showed for the first time that a fat blocker medication can significantly lessen the risk of developing type 2 diabetes.


                    [DatePublished] => 2004-05-27 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 250481
                    [Title] => Watch out for this sly killer on the loose
                    [Summary] => This killer syndrome is on the loose, preying on millions of unsuspecting victims. Victim No. 1: Ricardo B., 54-year-old insurance manager, complained of no symptoms previously and could still play 18 holes of golf without using the golf cart; just slightly overweight; with borderline blood pressure (BP) and blood sugar (BS); low high-density lipoprotein or HDL (good cholesterol) and elevated triglycerides; rushed to the emergency room for an acute myocardial infarction (heart attack); and fortunately survived. 


                    [DatePublished] => 2004-05-18 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1769986
                    [AuthorName] => The Fame Health Bureau
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Reducing diabetes risk

May 27, 2004 - 12:00am

Treatment of type 2 diabetes has recently acquired a new development as the European Commission (EC) recently approved the use of the weight loss medication, orlistat, in managing and reducing the risk for developing...

Science and Environment

Watch out for this sly killer on the loose

By The Fame Health Bureau | May 18, 2004 - 12:00am

This killer syndrome is on the loose, preying on millions of unsuspecting victims. Victim No. 1: Ricardo B., 54-year-old insurance manager, complained of no symptoms previously and could still play 18 holes of golf...

Health And Family